Efficacy and safety of navigated repetitive transcranial magnetic stimulation in the treatment of Alzheimer's disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027841

Enrollment

Unknown

Registered

2019-11-30

Start date

2019-12-01

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

therapy group:Navigation positioned rTMS

control group:false stimulation

Traditional treatment group:Traditionally positioned rTMS

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Alzheimer's disease dementia patients who have been diagnosed by at least 2 deputy chief physicians and above to meet the diagnostic criteria for ICD-10.

Exclusion criteria

Exclusion criteria: Patients with a history of epilepsy; those with contraindications for transcranial magnetic stimulation; those who cannot be treated with brain magnetic resonance and transcranial magnetic stimulation; cognitive dysfunction associated with physical illness; and major physical illnesses.

Design outcomes

Primary

Measure	Time frame
MMSE;MoCA;ADL;NPI;CDR;CGI;	—

Secondary

Measure	Time frame
EEG;HAMD;HAMA;PSQI;NSE;S100b;APOE4;ERP;MRI;ECG;	—

Countries

China

Contacts

Public ContactYongjun Wang

Shenzhen Kangning Hospital

wangyj1931@163.com+86 13632587615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026